Tradestie Institutional Equity Comparison Engine

UL vs CL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CL Overall Edge

CL Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Colgate-Palmolive Company (CL) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while UL counters with relative strength in Valuation. Fundamentally, UL trades at 18.5x Forward P/E with 20.0% operating margin (+0.5% YoY revenue) versus CL at 24.1x Forward P/E and 20.7% operating margin (+4.6% YoY). In options structure, UL sits in UNCLASSIFIED (13th %ile IV; Dealer Gamma Walls on Pro) against CL sits in SURGE (9th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner UL
UL 18.5x vs CL 24.1x Fwd P/E
Growth & Margin Winner CL
Op Margin 20.0% vs 20.7% ยท YoY +0.5% vs +4.6%
Momentum & Technical Winner CL
1Y +8.4% vs +25.8% ยท 52W Pos 45% vs 88%
Options & Structure Winner CL
UNCLASSIFIED (13th %ile IV) vs SURGE (9th %ile IV)
UL NYSE
Unilever plc
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
$63.82
+0.73% 1D
Market Cap $136.4B
1M Return -4.75%
1Y Return +8.41%
Forward P/E 18.5x
Unified AI Score
46.7 / 100 HOLD
Tech 47.0 Fund 45.0 Flow 50.0 Mom 36.0
CL NYSE
Colgate-Palmolive Company
Perfumes, Cosmetics & Other Toilet Preparations
$98.71
+1.89% 1D
Market Cap $77.0B
1M Return +1.36%
1Y Return +25.79%
Forward P/E 24.1x
Unified AI Score
32.6 / 100 SELL
Tech 28.0 Fund 40.0 Flow 56.0 Mom 25.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: UL +8.41% CL +25.79% Spread: +17.38 pp (CL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
UL TTM Op. Margin: 20.0% CL TTM Op. Margin: 20.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UL vs CL. Trailing 12-month operating profitability (UL 20.0% vs CL 20.7%) and valuation multiples (UL 18.5x vs CL 24.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: UL (6) vs CL (4)
Institutional Metric UL CL Criterion Row Winner
Market Capitalization Scale $136.4B $77.0B Larger Scale UL
Trailing P/E Ratio Valuation 13.0x 38.4x Lower Multiple UL
Forward P/E Ratio Valuation 18.5x 24.1x Lower Multiple UL
Revenue Growth (YoY) Growth +0.5% +4.6% Higher Growth CL
Operating Margin (TTM) Profitability 20.0% 20.7% Higher Margin CL
Net Profit Margin Profitability 18.3% 9.7% Higher Margin UL
Return on Equity (ROE) Capital Efficiency 31.9% 231.7% Higher ROE CL
52-Week Range Position Momentum 45% ($55โ€“$75) 88% ($76โ€“$102) Stronger Trend CL
Beta / 30D Volatility Risk Regime -0.03ฮฒ ยท 24% Vol -0.05ฮฒ ยท 28% Vol Lower Realized Risk UL
Unified Institutional Score Composite Signal 46.7 / 100 (HOLD) 32.6 / 100 (SELL) Higher Composite UL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full UL vs CL Buy Guide
UL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live UL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CL SURGE
5d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live CL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither UL nor CL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.